Hannah Joseph Hospital IPO GMP Today, Review & Verdict
GMP Today
Min Investment
Price Band
₹67 – ₹70
₹67 – ₹70
Market Cap
Live Market Desk – 6 February Update:
Grey Market Premium remains muted at ₹0–₹1, indicating cautious market sentiment around the issue. Early subscription trends are weak across all investor categories, suggesting limited immediate institutional interest.
Healthcare SME IPOs typically witness stronger demand toward the final day, as investors wait for clearer subscription signals and pricing comfort.
Capital Flow Insight:
If total subscription moves into the 2.5×–4× range by the close, listing sentiment could improve. Otherwise, the issue may see a flat to marginal listing.
Grey Market Signal:
GMP: ₹0–₹1
Estimated Listing Price: ₹70–₹71
Expected Listing Gain: 0%–2%
📊 IPO Snapshot
| Issue Type | SME IPO – Fresh Issue |
| Issue Size | ₹39.90 Crore |
| Fresh Shares | ~5,70,000 Shares |
| Price Band | ₹67 – ₹70 |
| Lot Size | 2,000 Shares |
| Minimum Investment | ₹1,40,000 |
| Exchange | BSE SME |
| Registrar | Bigshare Services Pvt Ltd |
| Lead Manager | Beeline Capital Advisors Pvt Ltd |
| Post-IPO Market Cap | ₹145 – ₹155 Crore (Estimated) |
📅 IPO Timeline
| Opening Date | 22 Jan 2026 |
| Closing Date | 27 Jan 2026 |
| Allotment Date | 28 Jan 2026 |
| Refund Date | 29 Jan 2026 |
| Demat Credit | 30 Jan 2026 |
| Listing Date | 30 Jan 2026 (Expected) |
📊 Subscription Status (Live)
| Category | Subscription | Shares Offered | Shares Bid |
|---|---|---|---|
| Retail | 0.04x | 1,99,500 | 7,980 |
| NII / HNI | 0.24x | 85,500 | 20,520 |
| QIB | 0.00x | 2,85,000 | 0 |
| Total | 0.07x | 5,70,000 | 28,500 |
🏥 Company Overview
Hannah Joseph Hospital operates a multi-specialty healthcare facility offering surgery, diagnostics, ICU, emergency care, and outpatient services. Revenue growth depends on patient volumes, occupancy rates, and operational efficiency.
💰 Use of IPO Proceeds
- Hospital infrastructure expansion
- Medical equipment purchase
- Working capital
- Debt repayment
👥 Shareholding Structure
| Pre-IPO Promoter Holding | 100% |
| Post-IPO Promoter Holding (Est.) | ~73% – 75% |
| Public Shareholding | ~25% – 27% |
💰 Financial Performance (₹ Cr)
| Year | Revenue | PAT | EBITDA Margin |
|---|---|---|---|
| FY2023 | 52.3 | 2.14 | 21.4% |
| FY2024 | 64.8 | 3.06 | 22.6% |
| FY2025 | 78.9 | 4.12 | 23.8% |
📊 Balance Sheet Snapshot (FY25)
| Total Assets | ₹142 Cr |
| Net Worth | ₹56 Cr |
| Total Debt | ₹41 Cr |
💵 Cash Flow Snapshot (FY25)
| Operating Cash Flow | ₹6.1 Cr |
| Investing Cash Flow | -₹4.6 Cr |
| Financing Cash Flow | ₹3.2 Cr |
📊 Valuation Metrics
| EPS (Post IPO) | ₹4.7 – ₹5.0 |
| P/E Ratio | ~14x – 15x |
| ROE | 22% – 24% |
| Debt to Equity | 0.70 – 0.80 |
🎯 Listing Scenario Model
| Bear Case | ₹65 – ₹69 |
| Base Case | ₹70 – ₹74 |
| Bull Case | ₹75 – ₹82 |
⚖️ Risk vs Reward Matrix
| Listing Gain Probability | 25% – 40% |
| Flat Listing Probability | 40% – 50% |
| Loss Probability | 15% – 25% |
🏁 Final Verdict
Hannah Joseph Hospital IPO shows weak early demand and nil GMP. Fundamentals are stable but SME liquidity risk and low subscription limit listing upside unless final-day momentum improves.
- Listing traders: Apply selectively
- High-risk investors: Small exposure only
- Conservative investors: Avoid
⚠️ GMP is unofficial and speculative. It can change rapidly.
Subscription quality matters more than GMP in SME IPOs.
Disclaimer: Educational content only. IPO investments involve market risks. Consult a SEBI-registered advisor before investing.
About The Author
